Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.42 |
| ▸ | MGAM | O43451 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | SI | P14410 | 1/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14865765 | 0.80 | HSD17B10 (0.42) | ALDH1A1CYP3A4ALOX15TDP1TSHR | |
| SCHEMBL14865763 | 0.77 | CYP1A2 (0.41) | ALDH1A1CYP3A4TDP1HSD17B10MGAM | |
| SCHEMBL14865767 | 0.71 | HSD17B10 (0.44) | ALDH1A1CYP3A4ALOX15TDP1HSD17B10 | |
| SCHEMBL28162657 | 0.70 | USP2 (0.47) | ALDH1A1CYP3A4ALOX15HSD17B10MGAM | |
| SCHEMBL20239635 | 0.69 | ALDH1A1 (0.57) | ALDH1A1CYP3A4ALOX15TDP1TSHR | |
| SCHEMBL715975 | 0.69 | ALDH1A1 (0.61) | ALDH1A1CYP3A4ALOX15TDP1TSHR | |
| SCHEMBL11172402 | 0.68 | ALDH1A1 (0.49) | ALDH1A1CYP3A4ALOX15TDP1TSHR | |
| SCHEMBL3677733 | 0.67 | MGAM (0.44) | ALDH1A1CYP3A4ALOX15TDP1TSHR | |
| SCHEMBL3676097 | 0.67 | MGAM (0.44) | ALDH1A1CYP3A4ALOX15TDP1TSHR | |
| SCHEMBL3676100 | 0.67 | MGAM (0.44) | ALDH1A1CYP3A4ALOX15TDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8530559-B2 | Composite of organic compound and copper nanoparticles, composite of organic compound and copper(I) oxide nanoparticles, and methods for producing the composites | DIC CORPORATION (JP) | 2013-09-10 | — | — | US | disclosed |
| US-20130095320-A1 | COMPOSITE OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPOSITE OF ORGANIC COMPOUND AND COPPER(I) OXIDE NANOPARTICLES, AND METHODS FOR PRODUCING THE COMPOSITES | DIC CORPORATION (JP) | 2013-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130095320-A1 | COMPOSITE OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPOSITE OF ORGANIC COMPOUND AND COPPER(I) OXIDE NANOPARTICLES, AND METHODS FOR PRODUCING THE COMPOSITES | AOC3, AOC2, CORO1C | ALDH1A1 924/4885CYP3A4 981/4885ALOX15 674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.